# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k083462   
B. Purpose for Submission: New device   
C. Measurand: Calibrator material for lactate dehydrogenase   
D. Type of Test: Not applicable.   
E. Applicant: Siemens Healthcare Diagnostics Inc.   
F. Proprietary and Established Names: Dimension Vista $\textsuperscript { \textregistered }$ System Enzyme 5 Calibrator (ENZ 5 CAL)

# G. Regulatory Information:

1. Regulation section: 21 CFR § 862.1150 Calibrator   
2. Classification: Class II   
3. Product code: JIT, Calibrator, Secondary   
4. Panel: Clinical Chemistry (75)

# H. Intended Use:

1. Intended use(s): The ENZ 5 CAL is an in vitro diagnostic product for the calibration of the lactate dehydrogenase (LDI) method on the Dimension Vista $^ \mathrm { \textregistered }$ System.

2. Indication(s) for use: See Intended Use section above.

3. Special conditions for use statement(s): For prescription use only

4. Special instrument requirements: Dimension Vista $\textsuperscript { \textregistered }$ System

I. Device Description:

ENZ 5 CAL is a liquid, bovine serum albumin-based product containing lactate dehydrogenase from chicken heart. The calibrator consists of one level (Calibrator A), and comes packaged with three vials at $1 . 5 \mathrm { m L }$ per vial. System water (the zero level calibrator) does not come packaged with the calibrator. The calibrator contains preservatives and stabilizers.

J. Substantial Equivalence Information:

1. Predicate device name(s): Dimension $\textsuperscript { \textregistered }$ clinical system Enzyme I Calibrator

2. Predicate 510(k) number(s): k081789

Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Proposed Device</td><td rowspan=1 colspan=1>Predicate Device</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Lactate dehydrogenase.</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>For the calibration of the lactatedehydrogenase (LDI) method onthe Dimension Vista® System.</td><td rowspan=1 colspan=1>For the calibration of the lactatedehydrogenase (LDI) method onthe Dimension® clinical chemistrysystem.</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Liquid bovine serum albumin basewith lactate dehydrogenase ofchicken liver origin.</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Form</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>same</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>IFCC LD at 37 ° C primaryreference method.</td><td rowspan=1 colspan=1>same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Proposed Device</td><td rowspan=1 colspan=1>Predicate Device</td></tr><tr><td rowspan=1 colspan=1>Packaging</td><td rowspan=1 colspan=1>One Level  Calibrator A</td><td rowspan=1 colspan=1>Two Levels - Level 2 and Level 3</td></tr><tr><td rowspan=1 colspan=1>CalibrationLevels</td><td rowspan=1 colspan=1>Two Levels:System water is Level 1Calibrator A is Level 2</td><td rowspan=1 colspan=1>Three Levels:Purified Water Diluent or reagentgrade water is Level 1Level 2 CalibratorLevel 3 Calibrator</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Guidance:

y Guidance for Industry – Abbreviated 510 (k) Submissions for In Vitro Diagnostic Calibrators; February 22, 1999

L. Test Principle: Not applicable

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility: Not applicable

b. Linearity/assay reportable range: Not applicable

c. Traceability, Stability, Expected values (controls, calibrators, or methods): Traceability: The calibrator is traceable to the IFCC lactate dehydrogenase (LD) Reference Measurement Procedure

Value Assignment: The expected value of the commercial calibrator, Calibrator A, is assigned by measuring the recovery of the calibrator using three instruments (Dimension Vista $^ \mathrm { \textregistered }$ System) and three lactate dehydrogenase method (LDI) reagent lots. A previously assigned commercial lot is used as the control for the assignment for the new commercial lot.

Stability: Target shelf life for the Dimension Vista $\textsuperscript { \textregistered }$ ENZ 5 CAL is 12 months at $2 { - } 8 ^ { \circ } \mathrm { C }$ . Shelf life is determined by comparing results of the product stored at $2 { - } 8 ^ { \circ } \mathrm { C }$ with the control material stored at $\mathbf { - 2 0 } ^ { \textrm { o } } \mathbf { C }$ and $\mathbf { - 7 0 ^ { \circ } C }$ . Shelf life is also tested following three freeze-thaw cycles and three different stress testing routines. Real time and freeze-thaw stability testing is on-going.

The open vial stability for the Dimension Vista $\textsuperscript { \textregistered }$ ENZ 5 CAL is 30 days at 2- $8 ^ { \circ } \mathrm { C }$ . The punctured vial stability of the Dimension Vista $\textsuperscript { \textregistered }$ ENZ 5 CAL is 7 days at $2 { - } 8 ^ { \circ } \mathrm { C }$ .

d. Detection limit: Not applicable e. Analytical specificity: Not applicable

f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

N. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.